490 related articles for article (PubMed ID: 33860384)
1. Kv7 Channels and Excitability Disorders.
Jones F; Gamper N; Gao H
Handb Exp Pharmacol; 2021; 267():185-230. PubMed ID: 33860384
[TBL] [Abstract][Full Text] [Related]
2. The therapeutic potential of neuronal KCNQ channel modulators.
Gribkoff VK
Expert Opin Ther Targets; 2003 Dec; 7(6):737-48. PubMed ID: 14640909
[TBL] [Abstract][Full Text] [Related]
3. Kv7 channels as targets for the treatment of pain.
Wickenden AD; McNaughton-Smith G
Curr Pharm Des; 2009; 15(15):1773-98. PubMed ID: 19442190
[TBL] [Abstract][Full Text] [Related]
4. Electrophysiological and pharmacological characterization of a novel and potent neuronal Kv7 channel opener SCR2682 for antiepilepsy.
Zhang F; Liu Y; Tang F; Liang B; Chen H; Zhang H; Wang K
FASEB J; 2019 Aug; 33(8):9154-9166. PubMed ID: 31063701
[TBL] [Abstract][Full Text] [Related]
5. Activation of Kv7 (KCNQ) voltage-gated potassium channels by synthetic compounds.
Xiong Q; Gao Z; Wang W; Li M
Trends Pharmacol Sci; 2008 Feb; 29(2):99-107. PubMed ID: 18206251
[TBL] [Abstract][Full Text] [Related]
6. HCN and KV7 (M-) channels as targets for epilepsy treatment.
Shah MM; Huang Z; Martinello K
Neuropharmacology; 2013 Jun; 69():75-81. PubMed ID: 22446478
[TBL] [Abstract][Full Text] [Related]
7. Nonreciprocal mechanisms in up- and downregulation of spinal motoneuron excitability by modulators of KCNQ/Kv7 channels.
Lombardo J; Harrington MA
J Neurophysiol; 2016 Nov; 116(5):2114-2124. PubMed ID: 27512022
[TBL] [Abstract][Full Text] [Related]
8. Tannic acid modulates excitability of sensory neurons and nociceptive behavior and the Ionic mechanism.
Zhang X; Zhang H; Zhou N; Xu J; Si M; Jia Z; Du X; Zhang H
Eur J Pharmacol; 2015 Oct; 764():633-642. PubMed ID: 26134502
[TBL] [Abstract][Full Text] [Related]
9. Molecular determinants of KCNQ (Kv7) K+ channel sensitivity to the anticonvulsant retigabine.
Schenzer A; Friedrich T; Pusch M; Saftig P; Jentsch TJ; Grötzinger J; Schwake M
J Neurosci; 2005 May; 25(20):5051-60. PubMed ID: 15901787
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular KCNQ (Kv7) potassium channels: physiological regulators and new targets for therapeutic intervention.
Mackie AR; Byron KL
Mol Pharmacol; 2008 Nov; 74(5):1171-9. PubMed ID: 18684841
[TBL] [Abstract][Full Text] [Related]
11. Structural insight into KCNQ (Kv7) channel assembly and channelopathy.
Howard RJ; Clark KA; Holton JM; Minor DL
Neuron; 2007 Mar; 53(5):663-75. PubMed ID: 17329207
[TBL] [Abstract][Full Text] [Related]
12. Kv7/KCNQ/M-channels in rat glutamatergic hippocampal axons and their role in regulation of excitability and transmitter release.
Vervaeke K; Gu N; Agdestein C; Hu H; Storm JF
J Physiol; 2006 Oct; 576(Pt 1):235-56. PubMed ID: 16840518
[TBL] [Abstract][Full Text] [Related]
13. KV7 channelopathies.
Maljevic S; Wuttke TV; Seebohm G; Lerche H
Pflugers Arch; 2010 Jul; 460(2):277-88. PubMed ID: 20401729
[TBL] [Abstract][Full Text] [Related]
14. KCNQ-Encoded Potassium Channels as Therapeutic Targets.
Barrese V; Stott JB; Greenwood IA
Annu Rev Pharmacol Toxicol; 2018 Jan; 58():625-648. PubMed ID: 28992433
[TBL] [Abstract][Full Text] [
